XRMedix, a medical technology company that utilizes augmented reality, artificial intelligence, and computer vision to transform joint pain injections, was recently recognized at the TechConnect World Innovation Conference & Expo, earning a prestigious TechConnect Innovation Award.
About XRMedix
XRMedix, founded by Prabhakar Vemavarapu and Dr. Amarendar Kasarla, M.D., is a medical technology company revolutionizing how physicians approach needle guidance during joint pain injections. They use augmented reality technology to provide physicians with an intuitive, real-time experience that eliminates the need for radiological guidance and a separate screen. Their needle tracking technology enables physicians to guide the needle accurately while looking directly at the patient, similar to having “X-ray vision.”
The system uses off-the-shelf augmented reality glasses and enhanced needles, providing a quick registration process for patient, data, and procedural tools. The founders’ goal is to democratize joint pain injections, especially in areas with limited specialist availability, like rural areas. They are working to achieve this goal by empowering more physicians to treat more patients per day at a reduced cost compared to current standards and do these injections in examination rooms.
About the TechConnect Innovation Award
The TechConnect Innovation Award is a prestigious award that highlights the top innovations from around the world with the greatest potential for commercial impact.
Award winners are selected by a panel of expert judges who review and evaluate the submitted technologies, which are submitted from all over the world. The TechConnect Innovation Awards are highly competitive, and winning one is a testament to the quality and potential of the recognized technology.
The Selection Criteria for this award include:
- Potential Impact: The technology should have the potential to create a significant impact in a specific market or industry.
- Commercial Viability: The technology should be commercially viable, with a clear path to market adoption.
- Technical Innovation: The technology should demonstrate a high level of technical innovation and differentiation.
- Market Readiness: The technology should be at a stage of development that allows for near-term commercialization.
To learn more about XRMedix, visit https://xrmedix.com/
